Literature DB >> 23288540

Molecular characterization of the InvE regulator in the secretion of type III secretion translocases in Salmonella enterica serovar Typhimurium.

Jin Seok Kim1, Jung Im Jang, Jeong Seon Eom, Chang Heon Oh, Hyeon Guk Kim, Bae Hoon Kim, Iel Soo Bang, Seong Ho Bang, Yong Keun Park.   

Abstract

The type III secretion systems (T3SSs) are exploited by many Gram-negative pathogenic bacteria to deliver a set of effector proteins into the host cytosol during cell entry. The T3SS of Salmonella enterica serovar Typhimurium is composed of more than 20 proteins that constitute the membrane-associated base, the needle and the tip complex at the distal end of the T3SS needle. Membrane docking and piercing between the T3SS and host cells is followed by the secretion of effector proteins. Therefore, a secretion hierarchy among the substrates of the T3SS is required. The secretion of the pore-forming translocase proteins SipB, SipC and SipD is controlled by the T3SS regulator protein, InvE. During an attempt to identify the regions of InvE that are involved in T3SS regulation, it was observed that the secretion of SipB, SipC and SipD was inhibited when the C-terminal 52 amino acids were removed from InvE. In addition, InvE derivatives lacking the N-terminal 30 and 100 residues were unable to secrete translocases into the culture medium. Interestingly, in the absence of the N-terminal 180 residues of InvE, SipD is unstable, resulting in the hypersecretion of SipB. We also found that both the type III secretion signals of SipB and SptP were functionally interchangeable with the first 30 amino acids of InvE, which could allow the secretion of a reporter protein. These results indicate that InvE may have two functional domains responsible for regulating the secretion of translocases: an N-terminal secretion signal and a C-terminal regulatory domain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23288540     DOI: 10.1099/mic.0.061689-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  7 in total

1.  Regulation of Type III Secretion of Translocon and Effector Proteins by the EsaB/EsaL/EsaM Complex in Edwardsiella tarda.

Authors:  Lu Yi Liu; Pin Nie; Hong Bing Yu; Hai Xia Xie
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

2.  Dynamics of sequestration-based gene regulatory cascades.

Authors:  Tatenda Shopera; William R Henson; Tae Seok Moon
Journal:  Nucleic Acids Res       Date:  2017-07-07       Impact factor: 16.971

3.  Prevalence, co-infection and seasonality of fecal enteropathogens from diarrheic cats in the Republic of Korea (2016-2019): a retrospective study.

Authors:  Ye-In Oh; Kyoung-Won Seo; Do-Hyung Kim; Doo-Sung Cheon
Journal:  BMC Vet Res       Date:  2021-12-01       Impact factor: 2.741

4.  Structural and Functional Analysis of SsaV Cytoplasmic Domain and Variable Linker States in the Context of the InvA-SsaV Chimeric Protein.

Authors:  Jinghua Xu; Jiuqing Wang; Aijun Liu; Yanqing Zhang; Xiang Gao
Journal:  Microbiol Spectr       Date:  2021-12-01

5.  Genetically engineered frameshifted YopN-TyeA chimeras influence type III secretion system function in Yersinia pseudotuberculosis.

Authors:  Ayad A A Amer; Tiago R D Costa; Salah I Farag; Ummehan Avican; Åke Forsberg; Matthew S Francis
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

6.  YopN and TyeA Hydrophobic Contacts Required for Regulating Ysc-Yop Type III Secretion Activity by Yersinia pseudotuberculosis.

Authors:  Ayad A A Amer; Jyoti M Gurung; Tiago R D Costa; Kristina Ruuth; Anton V Zavialov; Åke Forsberg; Matthew S Francis
Journal:  Front Cell Infect Microbiol       Date:  2016-06-21       Impact factor: 5.293

7.  SalmoNet, an integrated network of ten Salmonella enterica strains reveals common and distinct pathways to host adaptation.

Authors:  Aline Métris; Padhmanand Sudhakar; David Fazekas; Amanda Demeter; Eszter Ari; Marton Olbei; Priscilla Branchu; Rob A Kingsley; Jozsef Baranyi; Tamas Korcsmáros
Journal:  NPJ Syst Biol Appl       Date:  2017-10-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.